FEMA549984

TFPI Recombinant Human Monoclonal Antibody (3A8), Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 FEMA549984-Each-of-1 In Stock ₹ 37,202.00

FEMA549984 - Each of 1

₹ 37,202.00

In Stock

Quantity

1

Base Price: ₹ 37,202.00

GST (18%): ₹ 6,696.36

Total Price: ₹ 43,898.36

Antigen

TFPI

Classification

Recombinant Monoclonal

Concentration

0.5 mg/mL

Formulation

PBS with 50% glycerol and 0.03% Proclin 300, pH 7.4

Gene Accession No.

P10646, P19761

Gene Symbols

TFPI

Immunogen

Recombinant Human TFPI protein

Quantity

100 μL

Primary or Secondary

Primary

Target Species

Human, Rabbit

Form

Liquid

Applications

ELISA, Neutralization

Clone

3A8

Conjugate

Unconjugated

Gene

TFPI

Gene Alias

A630013F22Rik, anti-convertin, AW552122, EPI, Extrinsic pathway inhibitor, LACI, Lipoprotein-associated coagulation inhibitor, OTTHUMP00000163472, OTTHUMP00000205431, TFI, TFPI, TFPI1, Tissue factor pathway inhibitor, tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)

Host Species

Human

Purification Method

Affinity chromatography

Regulatory Status

RUO

Gene ID (Entrez)

100009401, 7035

Content And Storage

-20°C or -80°C if preferred

Isotype

IgG1

Related Products

Img

Thermo Scientific

FEMA549971

--

Img

Thermo Scientific

FEMA550084

--

Img

Thermo Scientific

FEMA549964

--

Img

Thermo Scientific

FEMA550255

--

Img

Thermo Scientific

FEMA551192

--

Img

Thermo Scientific

FEMA550259

--

Img

Thermo Scientific

FEMA549975

--

Img

Thermo Scientific

FEMA549822

--

Description

  • Tissue factor pathway inhibitor (TFPI), also known as lipoprotein-associated coagulation inhibitor, is a protease inhibitor that regulates the tissue factor (TF)-dependent pathway of blood coagulation
  • TFPI is glycosylated and predominantly found in the vascular endothelium and plasma in both free forms and complexed with plasma lipoproteins
  • The coagulation process initiates with the formation of a factor VIIa-TF complex, which proteolytically activates additional proteases (factors IX and X) and μgtimately leads to the formation of a fibrin clot
  • TFPI inhibits the activated factor X and VIIa-TF proteases in an autoregulatory loop.